Creative Planning
BIAF icon

Creative Planning’s bioAffinity Technologies BIAF Stock Holding History

Creative Planning’s Portfolio BIAF Stock Details BIAF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-27
Closed -$3.47K – 3923
2025
Q2 		$3.47K Hold
27
– – ﹤0.01% 3653
2025
Q1 		$3.15K Hold
27
– – ﹤0.01% 3448
2024
Q4 		$11K Hold
27
– – ﹤0.01% 3380
2024
Q3 		$25.2K Sell
27
-1
-4% -$899 ﹤0.01% 3139
2024
Q2 		$27.2K Buy
28
+1
+4% +$1.04K ﹤0.01% 2970
2024
Q1 		$24.4K Hold
27
– – ﹤0.01% 2826
2023
Q4 		$17.8K Hold
27
– – ﹤0.01% 2702
2023
Q3 		$14.1K Hold
27
– – ﹤0.01% 2618
2023
Q2 		$22.1K Hold
27
– – ﹤0.01% 2501
2023
Q1 		$22.9K Hold
27
– – ﹤0.01% 2401
2022
Q4 		$19.4K Sell
27
-39
-59% -$44.4K ﹤0.01% 2316
2022
Q3 		$86K Buy
+66
New +$125K ﹤0.01% 2052

Other funds holding BIAF

SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
SRL
Scientech Research LLC Jersey City, New Jersey $123M AUM 198.31% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AF
Allworth Financial Folsom, California $23.6B AUM 20.99% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
LFG
Larson Financial Group St Louis, Missouri $3.81B AUM 32.31% 1-Year Est. Return

Creative Planning's BIAF Position: Q3 2025 in Review

Creative Planning sold out of bioAffinity Technologies (BIAF) in Q3 2025, closing a stake of 27 shares — an estimated $3.47K sold.

Creative Planning first reported a position in BIAF in Q3 2022 and held it in 12 quarters. The position peaked at $86K in Q3 2022. 11 funds tracked by Wall St. Rank hold BIAF as of Q3 2025.

  • Creative Planning reported no remaining bioAffinity Technologies position as of Q3 2025 after selling out during the quarter.
  • Creative Planning sold 27 bioAffinity Technologies shares in Q3 2025, an estimated $3.47K.
  • Creative Planning first reported a position in bioAffinity Technologies in Q3 2022 and held it in 12 quarters.
  • Creative Planning's bioAffinity Technologies position peaked at $86K in Q3 2022.
  • 11 funds tracked by Wall St. Rank held bioAffinity Technologies as of Q3 2025.

Based on Creative Planning's 13F filing for Q3 2025, filed 14 Nov 2025.